145 related articles for article (PubMed ID: 12744186)
1. [Researches on PEG-modified copolymer nanoparticle].
Chen W; Yang X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Mar; 20(1):143-7. PubMed ID: 12744186
[TBL] [Abstract][Full Text] [Related]
2. PEG-PLA block copolymer as potential drug carrier: preparation and characterization.
Ben-Shabat S; Kumar N; Domb AJ
Macromol Biosci; 2006 Dec; 6(12):1019-25. PubMed ID: 17128420
[TBL] [Abstract][Full Text] [Related]
3. A preliminary study on MeO-PEG-PLGA-PEG-OMe nanoparticles as intravenous carriers.
Duan Y; Xu J; Lin Y; Yu H; Gong T; Li Y; Zhang Z
J Biomed Mater Res A; 2008 Nov; 87(2):515-23. PubMed ID: 18186066
[TBL] [Abstract][Full Text] [Related]
4. [Characterization of Me. PEG-PLA copolymer nanoparticles prepared by modified spontaneous emulsion-solvent evaporation].
Dong J; Liu MX; Yang YJ; Xu HB; Yang XL
Yao Xue Xue Bao; 2004 Sep; 39(9):677-80. PubMed ID: 15606012
[TBL] [Abstract][Full Text] [Related]
5. In vitro macrophage uptake and in vivo biodistribution of long-circulation nanoparticles with poly(ethylene-glycol)-modified PLA (BAB type) triblock copolymer.
Shan X; Liu C; Yuan Y; Xu F; Tao X; Sheng Y; Zhou H
Colloids Surf B Biointerfaces; 2009 Sep; 72(2):303-11. PubMed ID: 19450955
[TBL] [Abstract][Full Text] [Related]
6. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable long-circulating polymeric nanospheres.
Gref R; Minamitake Y; Peracchia MT; Trubetskoy V; Torchilin V; Langer R
Science; 1994 Mar; 263(5153):1600-3. PubMed ID: 8128245
[TBL] [Abstract][Full Text] [Related]
8. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
9. pH-Sensitive nanoparticles as smart carriers for selective intracellular drug delivery to tumor.
Li XX; Chen J; Shen JM; Zhuang R; Zhang SQ; Zhu ZY; Ma JB
Int J Pharm; 2018 Jul; 545(1-2):274-285. PubMed ID: 29733971
[TBL] [Abstract][Full Text] [Related]
10. Polyethylenglycol-co-poly-D,L-lactide copolymer based microspheres: preparation, characterization and delivery of a model protein.
Dorati R; Genta I; Tomasi C; Modena T; Colonna C; Pavanetto F; Perugini P; Conti B
J Microencapsul; 2008 Aug; 25(5):330-8. PubMed ID: 18465305
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of MeO-PEG-PLGA-PEG-OMe copolymers as drug carriers and their degradation behavior in vitro.
Duan Y; Zhang Y; Gong T; Zhang Z
J Mater Sci Mater Med; 2007 Oct; 18(10):2067-73. PubMed ID: 17558481
[TBL] [Abstract][Full Text] [Related]
12. ABA and BAB type triblock copolymers of PEG and PLA: a comparative study of drug release properties and "stealth" particle characteristics.
He G; Ma LL; Pan J; Venkatraman S
Int J Pharm; 2007 Apr; 334(1-2):48-55. PubMed ID: 17116377
[TBL] [Abstract][Full Text] [Related]
13. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S
Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973
[TBL] [Abstract][Full Text] [Related]
14. Effects of poly(ethylene glycol) grafting density on the tumor targeting efficacy of nanoparticles with ligand modification.
Zhang S; Tang C; Yin C
Drug Deliv; 2015 Feb; 22(2):182-90. PubMed ID: 24215373
[TBL] [Abstract][Full Text] [Related]
15. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation.
Liu X; Zhang Z; Jiang Y; Hu Y; Wang Z; Liu J; Feng R; Zhang J; Huang G
Drug Deliv; 2015 Feb; 22(2):223-9. PubMed ID: 24559497
[TBL] [Abstract][Full Text] [Related]
16. Enzymatic PEGylated Poly(lactone-co-β-amino ester) Nanoparticles as Biodegradable, Biocompatible and Stable Vectors for Gene Delivery.
Chen Y; Li Y; Gao J; Cao Z; Jiang Q; Liu J; Jiang Z
ACS Appl Mater Interfaces; 2016 Jan; 8(1):490-501. PubMed ID: 26673948
[TBL] [Abstract][Full Text] [Related]
17. Preparation and Characterization of Copolymeric Polymersomes for Protein Delivery.
Nomani A; Nosrati H; Manjili HK; Khesalpour L; Danafar H
Drug Res (Stuttg); 2017 Aug; 67(8):458-465. PubMed ID: 28561240
[TBL] [Abstract][Full Text] [Related]
18. Technical aspects of preparing PEG-PLGA nanoparticles as carrier for chemotherapeutic agents by nanoprecipitation method.
Almoustafa HA; Alshawsh MA; Chik Z
Int J Pharm; 2017 Nov; 533(1):275-284. PubMed ID: 28943210
[TBL] [Abstract][Full Text] [Related]
19. PEG-PLGA copolymers: their structure and structure-influenced drug delivery applications.
Zhang K; Tang X; Zhang J; Lu W; Lin X; Zhang Y; Tian B; Yang H; He H
J Control Release; 2014 Jun; 183():77-86. PubMed ID: 24675377
[TBL] [Abstract][Full Text] [Related]
20. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
Essa S; Rabanel JM; Hildgen P
Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
